» Articles » PMID: 36298713

Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2022 Oct 27
PMID 36298713
Authors
Affiliations
Soon will be listed here.
Abstract

Selective gene delivery to a cell type of interest utilizing targeted lentiviral vectors (LVs) is an efficient and safe strategy for cell and gene therapy applications, including chimeric antigen receptor (CAR)-T cell therapy. LVs pseudotyped with measles virus envelope proteins (MV-LVs) have been retargeted by ablating binding to natural receptors while fusing to a single-chain antibody specific for the antigen of choice. However, the broad application of MV-LVs is hampered by the laborious LV engineering required for every new target. Here, we report the first versatile targeting system for MV-LVs that solely requires mixing with biotinylated adapter molecules to enable selective gene transfer. The analysis of the selectivity in mixed cell populations revealed transduction efficiencies below the detection limit in the absence of an adapter and up to 5000-fold on-to-off-target ratios. Flexibility was confirmed by transducing cell lines and primary cells applying seven different adapter specificities in total. Furthermore, adapter mixtures were applied to generate CAR-T cells with varying CD4/CD8-ratios in a single transduction step. In summary, a selective and flexible targeting system was established that may serve to improve the safety and efficacy of cellular therapies. Compatibility with a wide range of readily available biotinylated molecules provides an ideal technology for a variety of applications.

Citing Articles

PD1-Targeted Transgene Delivery to Treg Cells.

Zhuchkov V, Kravchenko Y, Frolova E, Chumakov S Viruses. 2025; 16(12.

PMID: 39772246 PMC: 11680301. DOI: 10.3390/v16121940.


Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia.

Atar D, Ruoff L, Mast A, Krost S, Moustafa-Oglou M, Scheuermann S Leukemia. 2024; 38(10):2183-2195.

PMID: 39095503 PMC: 11436361. DOI: 10.1038/s41375-024-02351-2.


Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways.

Chuangchot N, Jamjuntra P, Yangngam S, Luangwattananun P, Thongchot S, Junking M Breast Cancer Res. 2023; 25(1):86.

PMID: 37480115 PMC: 10362675. DOI: 10.1186/s13058-023-01684-7.


Implementation of Novel Affinity Ligand for Lentiviral Vector Purification.

Moreira A, Bezemer S, Faria T, Detmers F, Hermans P, Sierkstra L Int J Mol Sci. 2023; 24(4).

PMID: 36834764 PMC: 9966744. DOI: 10.3390/ijms24043354.

References
1.
Bender R, Muth A, Schneider I, Friedel T, Hartmann J, Pluckthun A . Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment. PLoS Pathog. 2016; 12(6):e1005641. PMC: 4900575. DOI: 10.1371/journal.ppat.1005641. View

2.
Arcangeli S, Bove C, Mezzanotte C, Camisa B, Falcone L, Manfredi F . CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome. J Clin Invest. 2022; 132(12). PMC: 9197529. DOI: 10.1172/JCI150807. View

3.
Frank A, Buchholz C . Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes. Mol Ther Methods Clin Dev. 2018; 12:19-31. PMC: 6216101. DOI: 10.1016/j.omtm.2018.10.006. View

4.
Jamali A, Kapitza L, Schaser T, Johnston I, Buchholz C, Hartmann J . Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors. Mol Ther Methods Clin Dev. 2019; 13:371-379. PMC: 6453803. DOI: 10.1016/j.omtm.2019.03.003. View

5.
Turtle C, Hanafi L, Berger C, Gooley T, Cherian S, Hudecek M . CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. J Clin Invest. 2016; 126(6):2123-38. PMC: 4887159. DOI: 10.1172/JCI85309. View